Corebridge Financial Inc. Lowers Stake in HCA Healthcare, Inc. $HCA

Key Points

• Corebridge Financial Inc. reduced its stake in HCA Healthcare by 5.5%, selling 2,715 shares and now holding 46,217 shares valued at approximately $15.97 million.
• Multiple institutional investors have recently adjusted their stakes in HCA Healthcare, with reports showing significant increase for some, like Bartlett & CO. Wealth Management LLC, which lifted its stake by 888.9%.
• HCA Healthcare has reported better-than-expected quarterly earnings of $6.84 per share, surpassing the consensus estimate of $6.20, and experienced a revenue increase of 6.4% year-over-year to $18.61 billion.

Corebridge Financial Inc. lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 46,217 shares of the company's stock after selling 2,715 shares during the period. Corebridge Financial Inc.'s holdings in HCA Healthcare were worth $15,970,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in the company. Avantax Advisory Services Inc. increased its position in HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after buying an additional 32 shares during the period. Horizon Investments LLC grew its stake in shares of HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after purchasing an additional 33 shares during the last quarter. Catalyst Financial Partners LLC grew its stake in shares of HCA Healthcare by 4.3% in the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after purchasing an additional 36 shares during the last quarter. RWA Wealth Partners LLC grew its stake in shares of HCA Healthcare by 2.0% in the 1st quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company's stock valued at $658,000 after purchasing an additional 37 shares during the last quarter. Finally, Moors & Cabot Inc. grew its stake in shares of HCA Healthcare by 4.8% in the 1st quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock valued at $297,000 after purchasing an additional 39 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.6%

NYSE HCA traded up $2.50 during mid-day trading on Thursday, reaching $407.55. 965,359 shares of the stock were exchanged, compared to its average volume of 1,154,093. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The business's fifty day simple moving average is $376.38 and its 200 day simple moving average is $356.08. The stock has a market capitalization of $95.36 billion, a PE ratio of 17.13, a PEG ratio of 1.27 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Morgan Stanley decreased their price target on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and issued a $444.00 price target on shares of HCA Healthcare in a research note on Tuesday. JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $401.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.